Adrenochrome

Adrenochrome
Structural formula of adrenochrome
Ball-and-stick model of the adrenochrome molecule
Names
IUPAC name
3-Hydroxy-1-methyl-2,3-dihydro-1H-indole-5,6-dione
Other names
Adraxone; Pink adrenaline
Identifiers
3D model (JSmol)
ChemSpider
ECHA InfoCard 100.000.176
Properties
C9H9NO3
Molar mass 179.18 g·mol−1
Density 3.264 g/cm³
Boiling point (decomposes, 115-120 °C)
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
N verify (what is YesYN ?)
Infobox references

Adrenochrome is a chemical compound with the molecular formula C9H9NO3 produced by the oxidation of adrenaline (epinephrine). The derivative carbazochrome is a hemostatic medication. Despite a similarity in chemical names, it is unrelated to chrome or chromium.

Chemistry

In vivo, adrenochrome is synthesized by the oxidation of epinephrine. In vitro, silver oxide (Ag2O) is used as an oxidizing agent.[1] Its presence is detected in solution by a pink color. The color turns brown upon polymerization.

Effect on the brain

Several small-scale studies (involving 15 or fewer test subjects) conducted in the 1950s and 1960s reported that adrenochrome triggered psychotic reactions such as thought disorder, derealization, and euphoria.[2] Researchers Abram Hoffer and Humphry Osmond claimed that adrenochrome is a neurotoxic, psychotomimetic substance and may play a role in schizophrenia and other mental illnesses.[3] In what they called the "adrenochrome hypothesis",[4] they speculated that megadoses of vitamin C and niacin could cure schizophrenia by reducing brain adrenochrome.[5][6] However, these hypotheses have never been scientifically accepted; adrenochrome is not currently believed to have any psychedelic properties.[7]

Law

Adrenochrome is unscheduled by the Controlled Substances Act in the United States, but if sold as a supplement, sales must conform to U.S. supplement laws. If sold for consumption as a food or drug, sales are regulated by the FDA.[8]

References

  1. MacCarthy, Chim, Ind. Paris 55,435(1946)
  2. John Smythies (2002). "The adrenochrome hypothesis of schizophrenia revisited". Neurotoxicity Research. 4 (2): 147–150. doi:10.1080/10298420290015827.
  3. Hoffer, A. Osmond, H., Smithies, J.; Schizophrenia: a new approach. Journal of Mental Science #100 (January, 1954)
  4. Hoffer, A (1990). "The Adrenochrome Hypothesis and Psychiatry". Retrieved 2011-07-25.
  5. Hoffer, A. and Osmond, H. The Hallucinogens (Academic Press, 1967).
  6. Hoffer, A., Osmond, H., & Smythies, J. (1994). An Evolutionary Defense Against Severe Stress. Schizophrenia: A New Approach (pp. 205221). Victoria, Canada: Journal of Orthomolecular Medicine
  7. "The controversy that these reports created just sort of died away, and the adrenochrome family has never been accepted as being psychedelic. No one in the scientific community today is looking in and about the area, and at present this is considered as an interesting historical footnote." As seen at: Alexander Shulgin and Ann Shulgin (1991). "#157 (TMA)". PiHKAL - A Chemical Love Story. Transform Press.
  8. Erowid. "Adrenochrome Law". Retrieved 2013-01-14.
  9. "Inspector Lewis Series Synopsis". Archived from the original on 2008-06-26.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.